Crossmark

Can we safely target the WNT pathway?

Crossref DOI link: https://doi.org/10.1038/nrd4233

Published Online: 2014-07-01

Published Print: 2014-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kahn, Michael
License Information

Text and Data Mining valid from 2014-07-01
More Information

Article History

First Online: 1 July 2014

Competing interests

: The author is a consultant and equity holder in Prism Pharma Co. Ltd.